Everything in Dentistry Is a Capital Problem Now

Five separate pressures. One common denominator. Most owners are treating the symptoms.

Walk into any dental practice owners' meeting this year and you'll hear five different complaints.

I can't find an assistant. My multiple came in lower than I expected. A DSO just opened two miles away. My landlord raised the rent again. Half my referrals never show up at the specialist.

Each one gets discussed as its own problem, with its own vocabulary and its own consultant. Staffing is an HR issue. Valuation is an M&A issue. Competition is a marketing issue. Real estate is a lease issue. Referrals are a systems issue.

They are not five problems.

They are one problem wearing five costumes, and the practices that recognize it early are going to spend the next three years quietly buying the practices that don't.

1. The staffing shortage is a pricing problem you can't price your way out of

Start with the number everyone in dentistry has heard and almost nobody has sat with.

Dental hygiene programs graduated the largest class on record in 2025. Enrollment in those programs is up 15% since 2021. Graduates reached 7,739 in 2024 and kept climbing.

The total dental workforce stayed essentially flat.

Hamza Asumah, MD, director of operations at Juniper Services, described the mechanism plainly: new graduates are replacing people who are burning out and retiring rather than expanding the pool. "The industry keeps pouring more water into a bucket that has holes in both the clinical and business ends."

On the assisting side the bucket has a wider hole and a narrower tap. Dental assisting program enrollment is down 5.2% since 2021. Forty-seven percent of dental assistants are considering a job change within two years, the highest of any role in dentistry. Eighty-four percent of them name higher pay as the reason. Satisfaction fell to 54% from 57% the prior year. Sixteen percent plan to retire within five years.

Meanwhile 36.7% of dentists were actively recruiting assistants in the first quarter of 2026, and nearly 70% called that recruiting very or extremely challenging.

The American Dental Hygienists' Association looked at the same landscape and concluded the shortage is a retention crisis rather than a supply crisis. The fix everyone agrees on is the same list: better compensation, better benefits, career pathways, onboarding, mentorship.

Every item on that list is an expense that lands on this quarter's P&L and pays back over years.

Which means retention is not won by the practice with the best intentions. It is won by the practice that can afford to act on them. And the practices that most need the staff are frequently the ones with the least room to outbid for it.

There is a second cost that never appears anywhere. When the assistant chair sits empty, the work does not disappear, it gets absorbed by the most expensive labor in the building. There is no line item called production the doctor didn't do because he was turning over the room. The shortage does not show up in your expenses. It shows up in your production, which is precisely why so many owners misdiagnose soft collections as a demand problem and buy marketing to fix a staffing problem.

2. The growth math inverted, and most owners haven't noticed

For twenty years, DSO growth meant acquisition. Buy the practice, buy the patient base, buy the cash flow.

Look at what actually happened in August 2026.

Becker's tracked DSO expansion across the five most active states — Florida, North Carolina, Texas, Idaho, Rhode Island. Of the nineteen moves listed, eleven were new practice openings. PDS Health opened de novos in Florida, Texas and Idaho. Aspen Dental opened in Punta Gorda, Selma and Elkin. Heartland opened in Clayton and Argyle. Nuvia opened its first Rhode Island location.

The acquisitions were still there — Park Dental agreed to buy Village Family Dental for up to $46 million, Sage picked up nine Florida practices — but the largest platforms in the country spent the month building at least as much as buying.

That is not a strategy preference. It is arithmetic. When acquisition multiples run hot and good targets are scarce, a buildout starts to look cheap. A de novo costs what it costs. An acquisition costs whatever competitive bidding decides it costs.

Two consequences follow, and they point in opposite directions.

If you are planning to sell, your leverage assumed the buyer had to buy something. If the largest platforms can open a new office for less than they'd pay for yours, you are no longer competing only against other sellers. You are competing against their option to build instead.

And note where they are building: Selma, North Carolina. Elkin. Kuna, Idaho. Clermont, Florida. Not dense metros, the kinds of markets where an independent owner reasonably assumed nobody would bother. A de novo two miles away does not buy your patients. It competes for them, which is a materially different threat and one almost nobody is planning for.

The flip side is the more useful one. If building is currently cheaper than buying, that math is available to independents too.

The answer to a platform opening nearby is usually not to sell. It is to be the better-capitalized operator in that market before they arrive.

3. The exit is being repriced, and part of the price is invisible

Three facts, reported separately, that belong together.

First: TUSK Practice Sales expects dental valuations to compress over time from today's 5x to 9x+ EBITDA toward a more conservative 4x to 6x.

Second: healthcare services deal count fell 18.5% year over year in the second quarter, according to PitchBook. Dental was among several sectors carrying aged inventory among private equity-backed companies, at least 20 companies with holding periods of seven years or more.

Third: DSO deals are being written with 60% to 85% of total consideration paid as cash at close.

Read those together.

A private equity fund buys to sell. The model runs three to five years. Seven years is past the plan, past the fund's expected life, and past the point where limited partners stop asking politely. And the exit door narrowed at exactly the moment more platforms need to get through it.

Now return to that third fact. If 60% to 85% comes as cash, then 15% to 40% does not. That remainder usually rides in the platform as rollover equity, the second bite everyone discusses warmly at signing.

Your second bite is only worth something if the platform exits.

If you sold into one of those twenty, your rollover is not an investment. It is a position you cannot sell, inside a company that cannot sell itself. You were paid for the part you negotiated hardest on. The part you accepted quickly now sits inside somebody else's problem.

Notice, too, why cash-at-close percentages keep climbing. Sellers worked this out. They are pricing the risk.

The structural backdrop is not slowing. Private practice ownership fell from 85% in 2005 to 73% in 2023. Solo practice fell from roughly 67% to about 50%. The ADA puts consolidation near 35%. But the terms are changing, and the terms are where the money actually lives.

4. Your rent is somebody else's bond

On September 1, an MB2 Dental property in Yuba City, California sold for $1.65 million.

Single tenant. A 6.3% cap rate. Bought by a 1031 exchange investor. All cash. Closed fourteen days from letter of intent.

Do the arithmetic that matters: a 6.3% cap on $1.65 million works out to roughly $104,000 a year in rent.

That is the product. The investor did not buy a building in Yuba City. He bought a dentist's rent check, and he priced it like a bond, because that is how it behaves. Dental practices do not skip rent. They do not relocate casually; the build-out is specialized and moving costs more than staying. Patients are geographic. The tenant is sticky by construction.

It is not an isolated print. In July, a three-tenant retail pad in Lexington, South Carolina anchored by a dental practice sold for $3.67 million, roughly $524 per square foot for 7,000 feet of suburban retail, on long-term triple-net leases with staggered expirations.

No financing contingency. No extended due diligence. Capital does not move that fast on things it considers risky.

Here is the part that should bother practice owners. You are the reason those assets are worth what they're worth. Your reliability is the yield. Your lease is the coupon. Your years of showing up are the underwriting. And if you lease, you are manufacturing all of it on someone else's balance sheet.

Which produces a genuine paradox: the investment market treats a dental tenant as near-bond-quality credit, while plenty of dentists are told they are too leveraged to finance the building they already occupy. Same tenant. Same rent. Opposite verdict.

5. The leak nobody measures

Buried inside a Heartland Dental product announcement in September was a number that deserves far more attention than it received.

Only about 15% to 30% of patients referred for specialty care follow through on the recommendation.

Invert it. Seventy to eighty-five percent of the time, you diagnose the problem, present it, get the patient to agree to see a specialist, and nothing happens.

Now consider who tracks that. Practices track case acceptance obsessively: presented, accepted, scheduled, completed. Every practice management system reports it. Nobody tracks referral completion, because the moment the patient walks out with a name and a phone number, the case leaves your system and never enters anyone else's.

The general dentist believes they referred. The specialist never knew the patient existed. And the patient returns eighteen months later with a worse version of the same problem.

That is not a patient-experience issue. It is likely the largest unbooked revenue line in dentistry, and it is invisible because it falls between two practices and belongs to neither.

Which is exactly why Heartland built a platform for it.

Read that as strategy rather than software: when you own the general practice and the specialty practice, closing that gap does not improve a hand-off.

It converts leakage into internal revenue. The platform is monetizing a number independents are simply losing, and both sides of the independent market sit on the wrong end of it.

The common denominator

Line the five up.

Winning the hire requires paying above what current margin comfortably allows. Competing with a de novo requires capital deployed before it produces revenue. Improving your multiple requires structural work, scale, service lines, ownership, that takes eighteen to thirty-six months to build. Owning your building requires financing an asset that investors will buy all-cash but lenders often won't lend you.

Capturing referral leakage requires bringing services in-house, which is capital equipment and staff before it is revenue.

Every one of them is a capital problem dressed as an operating problem.

And the cost picture underneath is not dramatic, which is precisely what makes it dangerous.

The ADA's Q2 2026 economic report found dental equipment and supply costs up 23% since January 2021 and hourly earnings for dental staff up 23% over the same period, against overall inflation of 27%. Nothing exploded. Costs tracked inflation. So far in 2026, staff wages are up 2.2% while inflation sits at 1.8%, wages now moving slightly faster.

Practices rarely fail from one dramatic event.

They fail from years of quiet margin compression against a loan payment that never moves. Debt service is the one line on the statement that does not adjust, and by the time an owner notices the squeeze in cash flow, the options for fixing it have usually already narrowed.

The larger players understand this explicitly, and they act on it in ways worth studying.

When Dental Care Alliance restructured in 2026, it eliminated more than $1.1 billion in debt, secured $95 million in new capital, and extended remaining maturities to 2031 — without filing Chapter 11. Lenders exchanged debt for equity rather than liquidating, which tells you something about how institutional capital views dentistry's underlying value.

When Lone Peak Dental Group closed a $170 million recapitalization in July led by TCW Steel City, the structure included a term loan, a revolving credit facility, and a delayed draw term loan earmarked for future acquisitions. Eleven locations followed that same month. Four more in Alabama by early September.

Lone Peak did not find four practices and then go looking for financing. The capital was committed before the target existed. When the opportunity appeared, they did not start a process, they made a phone call.

That is the whole lesson, and it scales down.

You are not competing against a platform's balance sheet. You are competing against its term sheet.

The advantage was built months earlier, in a financing conversation that had nothing to do with the deal that eventually used it.

What to actually do

Three things, none of them glamorous.

Name the constraint honestly. Before spending on marketing, confirm the problem is demand. If collections are soft while the schedule is full and the doctor is doing support work, the problem is capacity, not demand, and marketing will make it worse.

Arrange capital before you need it. Pre-approval, a line, a delayed-draw structure, the form matters less than the timing. Financing arranged after you find an opportunity is sixty to ninety days behind a competitor who arranged it first. In a market where good practices are scarce, the buyer who wins is not the one with the most money. It is the one who can close.

Look at the fixed obligations you haven't examined in three years. Practice loans, equipment leases, credit lines, all sitting at whatever rate you signed at, quietly absorbing the margin every operational improvement was supposed to protect. That is usually the largest single lever available, and it is the one owners check last.

Dentistry is not short of demand, skill, or opportunity. In 2026 it is short of headroom, and headroom, unlike the workforce pipeline or the acquisition market, is something an individual owner can actually do something about.

Capital4Healthcare has provided practice financing and practice recovery services to healthcare professionals nationwide since 1996, including practice acquisition loans, commercial real estate loans, refinancing and restructuring, equipment financing, partner buy-ins and buy-outs, and start-up capital. More at www.capital4healthcare.llc.

Sources

• Becker's Dental Review, "Will a larger hygienist pipeline solve dentistry's labor crisis?" — August 27, 2026

• Becker's Dental Review, "Why the dental assistant shortage could get worse" — August 28, 2026

• Becker's Dental Review, "Dental staffing wages up 23% since 2021: ADA" — July 31, 2026

• Becker's Dental Review, "Inside dentistry's shifting M&A landscape" — August 27, 2026

• Becker's Dental Review, "The 5 states where DSOs added the most in August" — September 4, 2026

• Becker's Dental Review, "California MB2 Dental office sold for $1.6M" — September 1, 2026

• Becker's Dental Review, "PDS Health-anchored retail pad in South Carolina sold for $3.7M" — July 23, 2026

• Becker's Dental Review, "Heartland Dental rolls out care coordination platform" — September 4, 2026

• Becker's Dental Review, "Lone Peak Dental Group acquires 4 Alabama offices" — September 4, 2026

• Dental Economics, "Dental Care Alliance's restructuring signals a new era for DSOs" — July 28, 2026

• Group Dentistry Now, "DSO Deal Roundup – July 2026" — August 1, 2026

• TUSK Practice Sales, Q3 2026 Dental Market Report — July 10, 2026

• American Dental Association, "State of the U.S. Dental Economy," Q1 and Q2 2026

• DentalPost, 2026 Dental Salary Survey Report